<DOC>
	<DOCNO>NCT01519037</DOCNO>
	<brief_summary>The aim study evaluate , healthy volunteer , acute modulate effect cinacalcet RAAS , effect furosemide parathyroid secretion PTH interaction furosemide cinacalcet parathyroid hormone secretion .</brief_summary>
	<brief_title>Interaction Between Calcimimetic Agent Renin Angiotensine Aldosterone System</brief_title>
	<detailed_description>The clinical trial monocentric ( Service Nephrology Hypertension CHUV , Lausanne ) include 24 patient . The volunteer get involve inclusion ( Inclusion Visit ) crossover study two double-blind period . The order two period ( placebo cinacalcet ) randomize . Each period comprise 3 day low-sodium diet ( 50 mmol Na+ per day , equivalent 3 gram salt/day ) , follow investigation day hospital subject study exposure cinacalcet placebo . The 2 period separate therapeutic wash-out last 14-28 day . The total length study per participant 1 , max . 2 month .</detailed_description>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<mesh_term>Calcimimetic Agents</mesh_term>
	<criteria>Healthy subject Male Age &gt; 18 &lt; 45 year old Caucasian Nonsmoker BMI &gt; 18 &lt; 25 Kg/m2 Normal clinical examination ECG normal , 12 lead Systolic arterial pressure ( SBP ) ≥100 ≤ 139 mmHg diastolic arterial pressure ( DBP ) ≥50 ≤ 89 mmHg ( 5 minute lie , 3 measurement 2minute interval ; Omron machine ; left arm ) Heart rate ( HR ) ≥ 45 ≤ 90 beats/min Subject capable understand write information write consent form . Subject must give write , date sign consent start trial procedure . • Female Age &lt; 18 &gt; 45 year old Electrolyte disturbance , define sodium , potassium , total ionized calcium , phosphate magnesium value outside laboratory 's reference value ( Inclusion Visit ) . Seropositive HIV , HBV HCV ( Inclusion Visit ) . Positive detection drug urine ( opiate , cannabinoids , cocaine , benzodiazepine , amphetamine barbiturate ) ( Inclusion Visit ) . Fall SBP &gt; DBP &gt; 10 mmHg stand 1 minute clinical manifestation postural hypotension ( Inclusion Visit ) . Any history disease clinically significant condition may gastrointestinal ( gastritis gastric ulcer ) , respiratory , psychiatric , neurological ( medical history convulsion ) , renal , hepatic cardiac diseases/conditions abnormal physical sign may interfere study 's objective . The investigator may disqualify subject valid medical psychiatric reason . Ongoing involvement 60 day prior Inclusion Visit another research study . Chronic use medication ( prescribe ) 4 week prior Inclusion Visit ( use medication paracetamol headache tolerate low dose possible . Use medication know CYP P450 3A4 inhibitor 12 week prior Inclusion Visit ( amiodarone , diltiazem , verapamil , ketoconazole , itraconazole , voriconazole , posaconazole , fluconazole , miconazol , ritonavir , nelfinavir , amprenavir , indinavir , atazanavir , erythromycin , clarithromycin , josamycin , telithromycin ) Donation blood , plasma and/or marrow 3 month prior Inclusion Visit Medical history dependence drug alcohol abuse define DSM IVR , criterion diagnose drug alcohol abuse dependence drug . Medical history intolerant reaction cinacalcet furosemide ( derivative sulfamides )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>calcimimetic agent</keyword>
	<keyword>RAAS</keyword>
	<keyword>renin</keyword>
	<keyword>aldosterone</keyword>
</DOC>